The selection of treatment for recurrent tumors depends on which therapy was initially used and the site of recurrence . Clinical trials evaluating new chemotherapy drugs should be considered for recurrent adrenocortical carcinoma . Recurrent pheochromocytoma is managed in the same way as metastatic disease.
